Cervico-vaginal foetal fibronectin: a predictor of cervical response at pre-induction cervical ripening

West Afr J Med. 2005 Oct-Dec;24(4):334-7. doi: 10.4314/wajm.v24i4.28228.

Abstract

Context: Not all pregnant women with an "unripe" cervix can be successfully ripened by the cervical ripening agents; therefore tests with predictive information are justified.

Objectives: To examine the effect of the presence of foetal fibronectin (FFN) in the cervico-vaginal secretions on pre-induction cervical ripening with either intravaginal Misoprostol or transcervical Foley catheter.

Methodology: Twenty (20) patients managed at a tertiary health institution in South-western Nigeria between March and May 2003 were randomised for cervical ripening by either intravaginal Misoprostol or Transcervical Foley catheters. Cervico-vaginal secretions were assessed for presence of FFN with Foetal Fibronectin Enzyme Immunoassay Kit (Adeza Corp.) prior to commencement of cervical ripening.

Main outcome measures: FFN status, Pre-ripening and Pre-induction modified Bishop scores and duration of cervical ripening.

Results: Ten of the fifteen patients with positive membrane immunoassay for FFN achieved ripened cervix (modified Bishop score > or = 6) within 6 - 12 hours of exposure to the agents of cervical ripening. In the FFN negative group, only 2 of the five patients achieved ripe cervix within the >12 - 18 hours period, the rest being in the >18 - 24 hours period.

Conclusion: Foetal fibronectin test may offer useful predictive information prior to institution of processes of cervical ripening in patients with unfavourable cervices.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Abortifacient Agents, Nonsteroidal / pharmacology*
  • Abortifacient Agents, Nonsteroidal / therapeutic use
  • Adult
  • Catheterization
  • Cervical Ripening / drug effects*
  • Cervix Uteri / drug effects*
  • Female
  • Fibronectins / analysis*
  • Fibronectins / drug effects
  • Glycoproteins / analysis*
  • Glycoproteins / drug effects
  • Humans
  • Immunoassay
  • Labor, Induced / methods
  • Misoprostol / pharmacology*
  • Misoprostol / therapeutic use
  • Pregnancy
  • Time Factors
  • Vagina / drug effects*

Substances

  • Abortifacient Agents, Nonsteroidal
  • FFN protein, human
  • Fibronectins
  • Glycoproteins
  • Misoprostol